TH37169A - The long-release mixture of the drug is encapsulated in a hyaluronic acid microparticle. - Google Patents
The long-release mixture of the drug is encapsulated in a hyaluronic acid microparticle.Info
- Publication number
- TH37169A TH37169A TH9801001095A TH9801001095A TH37169A TH 37169 A TH37169 A TH 37169A TH 9801001095 A TH9801001095 A TH 9801001095A TH 9801001095 A TH9801001095 A TH 9801001095A TH 37169 A TH37169 A TH 37169A
- Authority
- TH
- Thailand
- Prior art keywords
- drug
- long
- hyaluronic acid
- encapsulated
- average size
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title claims abstract 7
- 239000003814 drug Substances 0.000 title claims abstract 7
- 239000011859 microparticle Substances 0.000 title claims abstract 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims abstract 3
- 229920002674 hyaluronan Polymers 0.000 title claims abstract 3
- 229960003160 hyaluronic acid Drugs 0.000 title claims abstract 3
- 239000000203 mixture Substances 0.000 title claims 3
- 239000002245 particle Substances 0.000 claims abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract 3
- 102000004169 proteins and genes Human genes 0.000 claims abstract 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract 3
- 150000003839 salts Chemical class 0.000 claims abstract 3
- 150000001412 amines Chemical class 0.000 claims abstract 2
- 239000004615 ingredient Substances 0.000 claims 2
- 102000018997 Growth Hormone Human genes 0.000 claims 1
- 108010051696 Growth Hormone Proteins 0.000 claims 1
- 239000000122 growth hormone Substances 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Abstract
DC60 สาร ผสมยาปลดปล่อยยาวนานประกอบด้วยจุลอนุภาคของกรดไฮอะลูโรนิกหรือ เกลืออนินทรีย์ของมันและยาโปรตีนหรือเปปไทด์ที่ ได้รับการห่อหุ้มในจุลอนุภาคที่กล่าวมาแล้ว โดยที่ ขนาดเฉลี่ย ของจุลอนุภาคที่กล่าวมาแล้วอยู่ในช่วงจาก 0.1 ถึง 40 ไมโคร เมตร ส่วนผสมยาปลดปล่อยยายนานประกอบด้วยจุลอนุภาคของกรดไฮอะลูโรนิกหรือ เกลืออนินทรีย์ของมีนและยาโปรตีนหรือเปปไทด์ที่ ได้รับการบรรจุในจุลอนุภาคที่กล่าวมาแล้ว โดยที่ขนาดเฉลี่ย ของจุลอนุภาคที่กล่าวมาแล้วอยู่ในช่วงจาก 0.1 ถึง 40 ไมโคร เมตร สิทธิบัตรยา DC60 Long-release compound containing microparticles of hyaluronic acid or Its inorganic salts and protein drugs or peptides that It is encapsulated in the above microparticles where the average size of the aforementioned microparticles ranges from 0.1 to 40 μm. Inorganic salts of amine and protein drugs or peptides that Has been contained in the microscopic particles mentioned above Where is the average size The above microparticles range from 0.1 to 40 μm.
Claims (4)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH37169A true TH37169A (en) | 2000-02-14 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2256596A1 (en) | Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid | |
| ATE464885T1 (en) | METHOD FOR PRODUCING SOLID DELIVERY SYSTEMS FOR ENCAPSULATED AND NON-ENCAPSULED PHARMACEUTICAL ACTIVE INGREDIENTS | |
| BR0004152A (en) | Lipophilic microparticles containing a protein or antigen drug and prepared comprising the same | |
| CA2354034A1 (en) | Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period | |
| WO1996036314A3 (en) | Method for drug delivery to the pulmonary system | |
| UY23958A1 (en) | PROCEDURE FOR THE PREPARATION OF CONTROLLED-RELEASE DOSAGE FORMS OF AZITROMYCIN | |
| BR9812590B1 (en) | process for the preparation of masked taste pharmaceutical compositions. | |
| KR930016091A (en) | Method for preparing a solid dispersion of an almost water-insoluble drug | |
| KR950703935A (en) | Pharmaceutical compositions that block taste | |
| EA200401006A1 (en) | AEROSOL PREPARATIONS FOR THE INTRAINOUSIC INTRODUCTION OF DRUGS WITH OBTAINING SYSTEMIC ACTION | |
| DE3850823D1 (en) | Drug release system and method of manufacture. | |
| EA200000968A1 (en) | TWO-PHASE DELIVERY SYSTEM WITH ADJUSTABLE SHIPPING FOR PHARMACEUTICAL MEANS WITH HIGH SOLUBILITY AND METHOD | |
| MA26571A1 (en) | HYDROXAMIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION | |
| KR910011244A (en) | Lozenge | |
| CA2131366A1 (en) | Self-assembling diketopiperazine drug delivery system | |
| CA2266629A1 (en) | Taste-masked microcapsule compositions and methods of manufacture | |
| BR0003158A (en) | Instant melting oral dosage formulation | |
| EP1263453A4 (en) | PHARMACEUTICAL FORMULATION CONSISTING OF A POLYMERMATRIX, FOR REGULATING THE TIME-CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE SUBSTANCES | |
| EP1025840A3 (en) | Oral drug compositions and methods | |
| CA2432900A1 (en) | Induced phase transition method for the production of microparticles containing hydrophilic active agents | |
| ES2112253T3 (en) | SMALL PARTICULAR PHARMACY COMPOSITIONS. | |
| HRP20030108B1 (en) | Stable salts of o-acetylsalicyclic with basic amino acids | |
| FR2624863B1 (en) | NOVEL CRYSTALLINE FORM OF CICLOSPORIN, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
| AR006087A1 (en) | DOSAGE FORM FOR THE ADMINISTRATION OF VERAPAMIL CHLORHYDRATE AT A UNIFORM RELEASE RATE. | |
| ATE529097T1 (en) | PHARMACEUTICAL PREPARATION IN THE FORM OF A PASTE CONTAINING AN ACID LABEL ACTIVE INGREDIENT |